Rebecca Lou Lief-kuster, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4761 Coffee Lake Rd, Moose Lake, MN 55767 Phone: 218-341-0212 |
Keri A Halverson, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4572 County Road 61, Moose Lake, MN 55767 Phone: 218-485-4481 |
Tara Wittrock, CCC/SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4791 County Road 10 Ste 102, Moose Lake, MN 55767 Phone: 218-485-2020 Fax: 218-485-2044 |
Elizabeth Luoma, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4570 County Road 61, Moose Lake, MN 55767 Phone: 218-485-2020 |
News Archive
Two Massachusetts General Hospital (MGH)-based research teams, along with a group from the University of California at San Diego, have discovered that animals have a previously unknown system for detecting and responding to pathogens and toxins. In three papers published in the journals Cell and Cell Host & Microbe, the investigators describe finding evidence that disruptions to the core functions of animal cells trigger immune and detoxification responses, along with behavioral changes.
Over the last decade, neuroscientists have largely come to believe that physical pain and social pain are processed by the brain in the same way. But a new study led by the University of Colorado shows that the two kinds of pain actually use distinct neural circuits, a finding that could lead to more targeted treatments and a better understanding of how the two kinds of pain interact.
In the race for better treatments and possible cures, rare diseases are often left behind. In a collaboration of researchers at The Rockefeller University, Memorial Sloan Kettering Cancer Center and the New York Genome Center (NYGC), an unusual mutation has been found that is strongly linked to one such disease: a rare liver cancer that affects teens and young adults.
Novartis announced today new late-breaking data demonstrating that CosentyxTM provides high levels of skin clearance and sustained efficacy in patients with moderate-to-severe plaque psoriasis while maintaining a favorable safety profile across three years.
These stem cells can reproduce and be converted into various types of brain cells. To date, only reprogramming in brain cells that were already fully developed or which had only a limited ability to divide was possible. The new reprogramming method presented by the Bonn scientists and submitted for publication in July 2011 now enables derivation of brain stem cells that are still immature and able to undergo practically unlimited division to be extracted from conventional body cells.
› Verified 9 days ago